OC
RSPH icon

Oppenheimer & Co’s Invesco S&P 500 Equal Weight Health Care ETF RSPH Stock Holding History

Oppenheimer & Co’s Portfolio RSPH Stock Details RSPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$641K Buy
19,317
+264
+1% +$8.21K 0.01% 1147
2026
Q1 		$575K Sell
19,053
-11,807
-38% -$379K 0.01% 1134
2025
Q4 		$983K Sell
30,860
-609
-2% -$18.9K 0.01% 811
2025
Q3 		$925K Sell
31,469
-3,173
-9% -$91.9K 0.01% 930
2025
Q2 		$1.01M Sell
34,642
-1,450
-4% -$41.3K 0.01% 847
2025
Q1 		$1.07M Buy
36,092
+4,394
+14% +$133K 0.02% 775
2024
Q4 		$929K Sell
31,698
-31,348
-50% -$964K 0.01% 820
2024
Q3 		$2.03M Buy
63,046
+582
+0.9% +$18.2K 0.03% 549
2024
Q2 		$1.88M Buy
62,464
+8,024
+15% +$243K 0.03% 554
2024
Q1 		$1.73M Buy
54,440
+6,012
+12% +$185K 0.03% 555
2023
Q4 		$1.44M Buy
48,428
+2,543
+6% +$69.7K 0.03% 595
2023
Q3 		$1.26M Buy
45,885
+5,985
+15% +$174K 0.03% 593
2023
Q2 		$1.19M Buy
39,900
+3,070
+8% +$89.9K 0.02% 641
2023
Q1 		$1.07M Sell
36,830
-730
-2% -$21.2K 0.02% 665
2022
Q4 		$1.08M Buy
37,560
+4,650
+14% +$130K 0.02% 649
2022
Q3 		$827K Buy
32,910
+2,600
+9% +$71.3K 0.02% 716
2022
Q2 		$812K Buy
30,310
+2,980
+11% +$84.5K 0.02% 755
2022
Q1 		$838K Buy
27,330
+6,040
+28% +$181K 0.02% 809
2021
Q4 		$682K Buy
21,290
+910
+4% +$27.7K 0.01% 922
2021
Q3 		$608K Buy
20,380
+1,640
+9% +$50.5K 0.01% 936
2021
Q2 		$549K Buy
18,740
+7,100
+61% +$201K 0.01% 987
2021
Q1 		$312K Buy
11,640
+1,760
+18% +$46.8K 0.01% 1157
2020
Q4 		$258K Hold
9,880
– – 0.01% 1143
2020
Q3 		$233K Hold
9,880
– – 0.01% 1099
2020
Q2 		$220K Buy
+9,880
New +$211K 0.01% 1080
2020
Q1 		– Sell
-10,130
Closed -$224K – 1308
2019
Q4 		$224K Sell
10,130
-80
-0.8% -$1.67K 0.01% 1139
2019
Q3 		$200K Sell
10,210
-340
-3% -$6.77K 0.01% 1143
2019
Q2 		$214K Buy
10,550
+380
+4% +$7.39K 0.01% 1157
2019
Q1 		$201K Buy
+10,170
New +$196K 0.01% 1221

Other funds holding RSPH

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
STA
Summit Trail Advisors New York $7.95B AUM 26.49% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
WLPWM
Walled Lake Planning & Wealth Management Winnetka, Illinois $396M AUM 17.09% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
MCM
MAI Capital Management Independence, Ohio $26.6B AUM 22.97% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Oppenheimer & Co's RSPH Position: Q2 2026 in Review

Oppenheimer & Co increased its Invesco S&P 500 Equal Weight Health Care ETF (RSPH) stake by 1.4% in Q2 2026, buying an estimated $8.21K and bringing the position to 19,317 shares worth $641K. The position accounts for 0.01% of the portfolio, ranked #1147.

Oppenheimer & Co first reported a position in RSPH in Q1 2019 and has held it in 29 quarters since. The position peaked at $2.03M in Q3 2024. 188 funds tracked by Wall St. Rank hold RSPH as of Q2 2026.

  • Oppenheimer & Co held 19,317 shares of Invesco S&P 500 Equal Weight Health Care ETF worth $641K as of Q2 2026.
  • Oppenheimer & Co bought 264 Invesco S&P 500 Equal Weight Health Care ETF shares in Q2 2026, an estimated $8.21K.
  • Invesco S&P 500 Equal Weight Health Care ETF made up 0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1147 holding.
  • Oppenheimer & Co first reported a position in Invesco S&P 500 Equal Weight Health Care ETF in Q1 2019 and has held it in 29 quarters since.
  • Oppenheimer & Co's Invesco S&P 500 Equal Weight Health Care ETF position peaked at $2.03M in Q3 2024.
  • 188 funds tracked by Wall St. Rank held Invesco S&P 500 Equal Weight Health Care ETF as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.